Pharmacovigilance Study Comparing SGLT-2 Inhibitors(Empagliflozin And Dapagliflozin) Pro-arrhythmic Adverse Effects,A FAERS Database Study

Journal of Cardiac Failure 2026

View at publisher

Authors: Sadhana Jonna, Gunjan Mundhra, Suzanne Martinez, Andrea E. DeNeen, Yuhning Linda Hu

DOI: 10.1016/j.cardfail.2025.11.125

Cited by: 0

Fields of Study & Subjects

Pharmacovigilance and Adverse Drug Reactions Cardiac electrophysiology and arrhythmias Diabetes Treatment and Management